GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
108.66
+3.53 (3.36%)
Aug 11, 2025, 11:10 AM - Market open
Paramount Global Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$362,321
Profits / Employee
$1,406
Market Cap
3.12B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,000 | 0 | - |
Dec 31, 2023 | 1,000 | -100 | -9.09% |
Dec 31, 2022 | 1,100 | -100 | -8.33% |
Dec 31, 2021 | 1,200 | 328 | 37.61% |
Dec 31, 2020 | 872 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
WGS News
- 5 days ago - Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewsWire
- 5 days ago - GeneDx to Participate in Upcoming Investor Conferences - Business Wire
- 11 days ago - GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth - Seeking Alpha
- 11 days ago - WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group - PRNewsWire
- 11 days ago - GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 12 days ago - GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 14 days ago - WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm - PRNewsWire